Anti-Pyruvate dehydrogenase E2/E3bp antibody [13G2AE2BH5] and 1 more item
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0242717-V3
- Awardee
- Epitomics Inc
- Contracting organization
- University of Virginia
- Cumulative value
- $416.25
About this award
The University of Virginia awarded contract A207_PO-0242717-V3 to Epitomics Inc on August 8, 2026, for the procurement of laboratory reagents and related services. The contract encompasses the delivery of Anti-Pyruvate dehydrogenase E2/E3bp antibody [13G2AE2BH5] in vial format, with a quantity of 416 units at $1 per unit. This monoclonal antibody product is designated for research and diagnostic applications within the university's scientific operations.
The total cumulative contract value is $416. In addition to the primary antibody supply, the contract includes shipping and handling services at a unit price of $1. As the contracting organization, the University of Virginia serves as the buyer and point of delivery for all materials and services. Epitomics Inc, the awarded prime contractor, is responsible for fulfilling all delivery obligations under this purchase order.
Line items
| Item | Total |
|---|---|
| Anti-Pyruvate dehydrogenase E2/E3bp antibody [13G2AE2BH5] | $416.00 |
| shipping and handling | — |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0242717-V3?
Contract A207_PO-0242717-V3 was awarded to Epitomics Inc by University of Virginia on August 8, 2026.
How much is contract A207_PO-0242717-V3 worth?
Its cumulative value is $416.25.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award